Extracorporeal shock wave therapy for the management of burn scars

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Paolo FioramontiNicolo Scuderi

Abstract

Hypertrophic and contracture scars are common problems after burn injuries and cause functional and cosmetic deformities. A wide variety of treatments has been advocated for postburn pathologic scars regression. Unfortunately, the reported efficacy has been variable. To investigate the use of extracorporeal shock wave therapy (ESWT), which mainly targets the fibroblasts in scar tissue, as an effective modality for scar treatment in burn patients. An experimental study with ESWT was performed in 16 patients with postburn scars contractures, hypertrophic scars, or keloids twice a week for 6 weeks. Digital photographs were obtained and visual analogue scales were completed before and after treatment. Already after the first session, scars appeared more pliable, and color mismatch was less evident. At the end of the study period, all treated scars obtained a more acceptable appearance. Extracorporeal shock wave therapy is a feasible and cost-effective treatment in the management of postburn pathologic scars.

References

Jul 1, 1990·The Journal of Surgical Research·G Haupt, M Chvapil
Jun 13, 2001·Clinical Orthopaedics and Related Research·J A OgdenR Schultheiss
Feb 23, 2002·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Ching-Jen WangChun-Hwan Pai
Jun 22, 2002·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Lowell Scott WeilAnthony H Borrelli
Oct 14, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Ching-Jen WangLin-Cheng Yang
Jun 9, 2004·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Yeung-Jen ChenFeng-Sheng Wang
Oct 4, 2005·Burns : Journal of the International Society for Burn Injuries·R MeirerH Piza-Katzer
May 29, 2007·Journal of Reconstructive Microsurgery·Romed MeirerFlorian S Kamelger
Oct 2, 2007·The Journal of Surgical Research·Wolfgang SchadenAlexander Stojadinovic
Apr 9, 2008·Ultrasound in Medicine & Biology·R SagginiN Scuderi
Mar 24, 2009·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Piyush DuraniM W J Ferguson
Oct 2, 2009·Clinics in Plastic Surgery·David J Wainwright
Jan 15, 2010·Burns : Journal of the International Society for Burn Injuries·A ArnóJ P Barret

❮ Previous
Next ❯

Citations

Mar 30, 2016·The Journal of Surgical Research·Tobias KischRobert Kraemer
Oct 12, 2015·Ultrasound in Medicine & Biology·Raoul SagginiNicolò Scuderi
Aug 25, 2015·Journal of Tissue Viability·Tobias KischRobert Krämer
Aug 15, 2015·BioMed Research International·Tobias KischRobert Kraemer
Jan 26, 2016·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Letizia RinellaMaria Graziella Catalano
Sep 18, 2014·Annals of Rehabilitation Medicine·Yun Jae JungCheong Hoon Seo
Dec 24, 2019·Journal of Burn Care & Research : Official Publication of the American Burn Association·Ragab K ElnaggarMohammed A Elshafey
May 24, 2020·Dermatologic Therapy·Dong Hee KimYu Sung Choi
Feb 3, 2018·International Journal of Molecular Medicine·Jing-Chun ZhaoJia-Ao Yu
Feb 13, 2018·Experimental and Therapeutic Medicine·Jing-Chun ZhaoJia-Ao Yu
Sep 13, 2020·Burns : Journal of the International Society for Burn Injuries·Seung Yeol LeeCheong Hoon Seo
May 18, 2021·Burns : Journal of the International Society for Burn Injuries·A De CosmoR Elia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.